Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.

Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedFooter now includes references to the Moffitt Clinical Trials website and sponsor organization, plus a 'Helpful Links Provided by' attribution. The revision tag has been updated from v3.6.2 to v3.6.3.SummaryDifference0.2%

- Check20 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2. This indicates a newer page build without changes to the study content or data.SummaryDifference0.1%

- Check34 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', and new help sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added to assist users. The Intervention/Treatment header was reformatted to 'Intervention / Treatment' and the revision label updated to v3.6.0.SummaryDifference0.5%

- Check41 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This typically reflects minor updates or fixes applied to the page content or documentation.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page footer no longer shows branding lines for 'Moffitt Cancer Center Clinical Trials website' and 'H. Lee Moffitt Cancer Center and Research Institute' along with the 'Helpful Links Provided by' label. This changes how the sponsoring institution is presented and credited on the page.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.5.4 replaces Revision: v3.5.3 on the page, signaling a behind-the-scenes software update. This change does not affect the study details or how the page presents information.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.